Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutics of Alzheimer’s Disease: Recent Developments
Scott Burns, Ashley Selman, Ujala Sehar, et al.
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2402-2402
Open Access | Times Cited: 25

Showing 25 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 27
Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress
Víctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García‐Escudero
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 32
Disease-Modifying Treatments and Their Future in Alzheimer’s Disease Management
Blake Smith, Raymond L. Ownby
Cureus (2024)
Open Access | Times Cited: 10
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
Mitochondria-Targeted Delivery Strategy of Dual-Loaded Liposomes for Alzheimer’s Disease Therapy
Л. А. Васильева, Gulnara A. Gaynanova, Ф. Г. Валеева, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10494-10494
Open Access | Times Cited: 21
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice
Antonietta Vilella, Martina Bodria, Bianca Papotti, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 517-534
Open Access | Times Cited: 16
Alzheimer's disease and Alzheimer’s disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102178-102178
Closed Access | Times Cited: 15
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 6
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target
Nidhi Puranik, Minseok Song
Molecules (2024) Vol. 29, Iss. 23, pp. 5744-5744
Open Access | Times Cited: 6
Causal relationship between dementia and delirium: Insights from a bidirectional two-sample Mendelian randomization analysis
Yongsong Cai, Jiachen Wang, Xinyi Wang, et al.
Journal of Affective Disorders (2024) Vol. 349, pp. 69-76
Closed Access | Times Cited: 4
Identification of Therapeutic Potential of Hydroxychavicol Against Alzheimer’s Disease: An Integrated Network Pharmacology, Molecular Docking, and Dynamic Simulation Study
Priyank Upadhayay, Saurabh K. Sinha, Neeraj Kumar, et al.
Journal of Aging Research (2025) Vol. 2025, Iss. 1
Open Access
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
(2024)
Open Access | Times Cited: 3
Unlocking therapeutic potential: the role of adamantane in drug discovery
Chianna Dane, Grace A. Cumbers, Beau M. Allen, et al.
Australian Journal of Chemistry (2024) Vol. 77, Iss. 8
Open Access | Times Cited: 3
Covalent organic framework-based ratiometric electrochemical sensing platform for ultrasensitive determination of amyloid-β 42 oligomer
Jingjie Liu, H. Y. Zhao, S. Hu, et al.
Talanta (2024) Vol. 280, pp. 126699-126699
Closed Access | Times Cited: 3
Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias in African Americans: Focus on Caregivers
Jonathan Kopel, Ujala Sehar, Moumita Choudhury, et al.
Healthcare (2023) Vol. 11, Iss. 6, pp. 868-868
Open Access | Times Cited: 6
Alzheimer’s Disease: A Molecular Model and Implied Path to Improved Therapy
Meagan Susanne Weaver-Rosen, Philip Serwer
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3479-3479
Open Access | Times Cited: 2
Targeting Intrinsically Disordered Proteins (IDPs) in Drug Discovery
Sridhar Vemulapalli
(2024), pp. 493-517
Closed Access | Times Cited: 1
Blood-brain Transportable Peptides
Toshiro Matsui
Nippon Eiyo Shokuryo Gakkaishi (2024) Vol. 77, Iss. 1, pp. 29-35
Open Access
Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in Alzheimer's disease
Yufei Hou, Fang Liu, Nan Lin, et al.
Neurological Sciences (2024)
Closed Access
Targeting Alzheimer's Disease with Novel Dual-Function 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives
Aikaterini Katsogiannou, Danai Karta, Antonio Di Stefano, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100235-100235
Open Access
Gene Regulation by Nuclear Calcium and Its Antagonism by NMDAR/TRPM4 Signaling
Priit Pruunsild, C. Peter Bengtson, Jing Yan, et al.
(2024), pp. 113-170
Closed Access
Nitric oxide-mediated neuroinflammatory pathways as treatment targets in neurodegeneration
Jennifer Cale, Tracy D. Farr, Sébastien Serres, et al.
Elsevier eBooks (2024), pp. 79-96
Closed Access
Targeting Tau in Alzheimer’s and Beyond: Insights into Pathology and Therapeutic Strategies
Sunidhi Singh, Sumaiya Khan, Mohammad Shahid, et al.
Ageing Research Reviews (2024), pp. 102639-102639
Closed Access
Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 Mice
Monica N. Goodland, Subhashis Banerjee, Michael L. Niehoff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top